Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
10.1016/j.canlet.2011.03.001
Saved in:
Main Authors: | Lee, D.H., Thoennissen, N.H., Goff, C., Iwanski, G.B., Forscher, C., Doan, N.B., Said, J.W., Phillip Koeffler, H. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/126862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
by: Iwanski, G.B., et al.
Published: (2015) -
The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer
by: Aribi, A., et al.
Published: (2016) -
Sustained low-dose treatment with the Histone deacetylase inhibitor LBH589 induces terminal differentiation of osteosarcoma cells
by: Cain, J.E, et al.
Published: (2020) -
Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case report
by: Chong, L.L., et al.
Published: (2021) -
Erratum: Cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M cell cycle arrest
by: Suwit Duangmano, et al.
Published: (2017)